期刊文献+

Vero细胞传代过程中致瘤性的检测 被引量:4

Experimental investigation on tumorigenicity of Vero cell in the process of passage
原文传递
导出
摘要 目的为生物制品生产及研究用Vero细胞体系传代过程中的遗传安全性评价提供实验数据。方法对Vero细胞进行传代与冻存,并对不同代次Vero细胞进行体外与体内致瘤性检测,同时对不同代次Ver6细胞的蛋白质表达进行差异性分析。结果Vero细胞传代至270代并建立了14个细胞冻存库;不同代次Vero细胞体外与体内致瘤性检测结果均为阴性;200代以上的Vero细胞蛋白质表达水平有所变化。结论Vero细胞传代过程中虽然体外与体内致瘤性检测结果为阴性,但蛋白质组学分析有差异性蛋白表达,这为Vero细胞传代过程中的遗传安全性评价提供了实验参考。 Objective To produce an experimental information for the safety assessment of Vero cells during subculture. Methods Passage and freeze on Vero cells, and Vero cells in different passages in vitro and in vivo tumorigenicity were tested. The protein expression of different Vero cell passages was analyzed. Results Veto cells passaged to p270 and 14 cell banks were developed and stored for future evaluation. In vitro and in vivo tumorigenicity test results of Vero cells in different passages were negative. Conclusion Although the tumorigenicity test results in vitro and in vivo process were negative, the protein expression of more than p200 Vero cells were changed, which produced the experimental reference for the safety evaluation of the process during the Vero cell passage.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2011年第5期456-461,共6页 Chinese Journal of Microbiology and Immunology
基金 国家科技支撑计划(2008BA154804-02)
关键词 疫苗细胞基质 VERO细胞 传代安全性 致瘤性检测 蛋白质组学分析 Vaccine cell substrate Vero cell Safety of passages Test of tumorigenicity Pro- teomics analysis
作者简介 通信作者:王辉,Email:wh6247@sohu.com,电话:010-65762911
  • 相关文献

参考文献30

  • 1Montagnon BJ, Vincent-Falquet JC, Saluzzo JF. Experience with vero cells at Pasteur Mrrieux Connaught. Dev Biol Stand, 1999, 98 : 137-140 ; discussion 167.
  • 2Govorkova EA, Murti G, Meignier B, et al. African green monkey kidney (Vero) cells provide an ahemative host cell system for in- fluenza A and B viruses. J Virol, 1996, 70(8) : 5519-5524.
  • 3Choi Y, Ahn C J, Seong KM, et al. Inactivated Hantaan virus vac- cine derived from suspension culture of Veto ceils. Vaccine, 2003, 21(17-18) : 1867-1873.
  • 4丁志芬,石慧颖,庞成华,常振彦,赵敏,李荆,杨抗抗,刘培生.转瓶培养非洲绿猴肾传代细胞生产纯化流行性乙型脑炎疫苗的研究[J].中华医学杂志,1998,78(4):261-262. 被引量:7
  • 5Petricciani J. Cell substrates : where do we stand after 50 years of discussion? Dev Biol ( Basel), 2006, 123 : 11-21 ; discussion 55- 73.
  • 6张德礼.研制安全病毒疫苗[J].中国高校科技与产业化,2002(11):42-44. 被引量:1
  • 7Horaud F. Absence of viral sequences in the WHO-Vero Cell Bank. A collaborative study. Dev Biol Stand, 1992, 76: 43-46.
  • 8Manohar M, Orrison B, Peden K, et al. Assessing the tumorigenic phenotype of VERO cells in adult and newborn nude mice. Biolog- icals, 2008, 36 ( 1 ) : 65-72.
  • 9Zhang DL, Ji L, Li LJ, et al. Systematically experimental investi- gation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture. Yi Chuan Xue Bao, 2004, 31(7) : 647-660.
  • 10张德礼,李六金,夏耕田,何旭玉,高步先,白晓鸿,黄高升,刘尚高,阎隆飞,方福德,胡春雷,王黎军,姜焕宏,冯阿曼,张广民,安社刚,任远强,郭建民,胡淑贤,樊军喜,牛永利,宋占军,李迎,樊胜军.动物细胞系的染色体组型与遗传变异率分析[J].Acta Genetica Sinica,2001,28(4):327-344. 被引量:11

二级参考文献42

共引文献72

同被引文献27

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部